Showing results (61-70 of 100) with videos related to
Sort By:
Pageof 10
International Journal of Cancer|November 30, 2006
Pyrazolo-pyrimidine-derived c-Src inhibitor reduces angiogenesis and survival of squamous carcinoma cells by suppressing vascular endothelial growth factor production and signalingSandra Donnini, Martina Monti, Cinzia Castagnini, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 27, 2007
EP2 prostanoid receptor promotes squamous cell carcinoma growth through epidermal growth factor receptor transactivation and iNOS and ERK1/2 pathwaysSandra Donnini, Federica Finetti, Raffaella Solito, et al.Cancer Research|March 3, 2006
Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell linesNadia Lasagna, Ornella Fantappiè, Michela Solazzo, et al.Journal of Cell Science|March 1, 2013
Mitochondrial aldehyde dehydrogenase-2 activation prevents β-amyloid-induced endothelial cell dysfunction and restores angiogenesisRaffaella Solito, Federico Corti, Che-Hong Chen, et al.Cancers|December 11, 2019
ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 OutputErika Terzuoli, Cristiana Bellan, Sara Aversa, et al.Journal of Immunological Methods|January 22, 2003
Analysis of the role of chemokines in angiogenesisGiovanni Bernardini, Domenico Ribatti, Gaia Spinetti, et al.Cancer Research|August 26, 2010
Aminoflavone, a ligand of the aryl hydrocarbon receptor, inhibits HIF-1alpha expression in an AhR-independent fashionErika Terzuoli, Maura Puppo, Annamaria Rapisarda, et al.International Journal of Environmental Research and Public Health|July 24, 2021
Real-World Utilization of Target- and Immunotherapies for Lung Cancer: A Scoping Review of Studies Based on Routinely Collected Electronic Healthcare DataAndrea Spini, Giulia Hyeraci, Claudia Bartolini, et al.Endocrine-Related Cancer|June 27, 2015
mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicityFederica Finetti, Erika Terzuoli, Antonio Giachetti, et al.Cells|November 24, 2020
Amyloid-β Precursor Protein APP Down-Regulation Alters Actin Cytoskeleton-Interacting Proteins in Endothelial CellsEmma Ristori, Vittoria Cicaloni, Laura Salvini, et al.Pageof 10